Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Revenue Growth (1y) (2010 - 2026)

Analysis

Resmed (RMD) Revenue Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 13.02%
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 18.54%
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 13.73%
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 9.42%
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 7.53%
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 13.63%
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 13.08%
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 8.58%
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn 7.95%
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn 7.30%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.58%
Mar 31, 2026 10.81%
Dec 31, 2025 10.98%
Sep 30, 2025 9.07%
Jun 30, 2025 10.20%
Mar 31, 2025 7.92%
Dec 31, 2024 10.26%
Sep 30, 2024 11.08%
Jun 30, 2024 9.01%
Mar 31, 2024 7.17%
Dec 31, 2023 12.48%
Sep 30, 2023 16.00%
Jun 30, 2023 22.66%
Mar 31, 2023 29.20%
Dec 31, 2022 15.52%
Sep 30, 2022 5.12%
Jun 30, 2022 4.41%
Mar 31, 2022 12.45%
Dec 31, 2021 11.86%
Sep 30, 2021 20.22%